Drugs / WJ13404
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05662670 | Oct 2022 → Oct 2023 | — | Suzhou Junjing BioSciences Co., Ltd. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WJ13404 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05662670 ↗ |